Opendata, web and dolomites

SweetBrain SIGNED

A new perspective on the metabolic pathway to neuronal dysfunction: Using organs on a chip to elucidate the role of the brain microvasculature

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 SweetBrain project word cloud

Explore the words cloud of the SweetBrain project. It provides you a very rough idea of what is the project "SweetBrain" about.

ooc    suggest    hypothesize    mechanisms    underpinnings    perspective    drives    physiology    central    types    coupled    pass    diminish    neuronal    cure    scarcity    coupling    neurovascular    limitations    subsequently    unexplored    ignoring    vein    remaining    homeostasis    fundamental    unconsidered    glucose    clear    neurodegeneration    neurodegenerative    organ    model    brain    cutting    populations    elusive    human    hypothesis    revealed    models    nvu    interactions    disease    illuminating    regarding    astrocytes    gatekeeper    primarily    mainly    separately    little    observations    functional    diseases    functionally    treatment    metabolic    thereby    despite    metabolically    communications    nervous    function    altering    drawing    relationship    chip    metabolites    decades    diabetic    cns    revolutionize    modeling    cell    crosstalk    edge    grow    hyperglycemia    direct    correlated    dysfunction    capacity    questions    vasculature    neurons    elucidate    previously    metabolism    endothelium    pointing    levels    overcomes   

Project "SweetBrain" data sheet

The following table provides information about the project.

Coordinator
TEL AVIV UNIVERSITY 

Organization address
address: RAMAT AVIV
city: TEL AVIV
postcode: 69978
website: http://www.tau.ac.il/

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Israel [IL]
 Total cost 1˙487˙438 €
 EC max contribution 1˙487˙438 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2019-STG
 Funding Scheme ERC-STG
 Starting year 2020
 Duration (year-month-day) from 2020-07-01   to  2025-06-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    TEL AVIV UNIVERSITY IL (TEL AVIV) coordinator 1˙487˙438.00

Map

 Project objective

Despite decades of research, the underpinnings of central nervous system (CNS) diseases and clear pathways to effective treatment remain elusive, mainly because of a scarcity of adequate models and methods with the capacity to elucidate human brain physiology. Recent studies suggest that high glucose levels are correlated with neuronal dysfunction and neurodegeneration, yet very little is known about the mechanisms of this relationship. Research in this vein has focused primarily on direct metabolic interactions between neurons and astrocytes, ignoring other cell populations in the neurovascular unit (NVU) that might have a meaningful role. My recent research revealed that the brain vasculature—the ‘gatekeeper’ through which all metabolites must pass to reach the neurons—has direct metabolic coupling with the neurons. Drawing from these observations, I adopt a previously unconsidered perspective and propose that the vasculature drives the neurodegenerative effects of hyperglycemia. Specifically, I hypothesize that high glucose levels change the metabolic function of the brain vasculature, thereby altering the direct endothelium-neuronal crosstalk and triggering neuronal dysfunction. To investigate this hypothesis, I will develop cutting-edge Organ-on-a-Chip (OoC) technology that overcomes the limitations of modeling NVU functionality and cell-cell interactions. Specifically, I will: (1) establish a human-relevant NVU-OoC model for metabolic and functional interactions, in which different cell types grow separately while remaining metabolically and functionally coupled; (2) identify the major metabolic and functional interactions in the human NVU at homeostasis and under diabetic conditions; and subsequently (3) target the vasculature communications to diminish neuronal dysfunction. This research has the potential to revolutionize the study of CNS disease, pointing to an unexplored pathway to a cure, and illuminating fundamental questions regarding brain metabolism.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SWEETBRAIN" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SWEETBRAIN" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

CoolNanoDrop (2019)

Self-Emulsification Route to NanoEmulsions by Cooling of Industrially Relevant Compounds

Read More  

OAlipotherapy (2018)

Long-retention liposomic drug-delivery for intra-articular osteoarthritis therapy

Read More  

CHIPTRANSFORM (2018)

On-chip optical communication with transformation optics

Read More